trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Fibrosis D005355 23 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Hypersensitivity D006967 22 associated lipids
Medulloblastoma D008527 22 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Translocation, Genetic D014178 20 associated lipids
Leishmaniasis D007896 19 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
Carcinoma D002277 18 associated lipids
Uterine Neoplasms D014594 18 associated lipids
Brain Neoplasms D001932 15 associated lipids
Tongue Neoplasms D014062 15 associated lipids
Radiation Injuries D011832 14 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Neoplasms D009369 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Sciatic Neuropathy D020426 13 associated lipids
Keloid D007627 12 associated lipids
Cat Diseases D002371 12 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Retinoblastoma D012175 12 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Mast-Cell Sarcoma D012515 9 associated lipids
Fetal Growth Retardation D005317 9 associated lipids
Chondrosarcoma D002813 9 associated lipids
Enteritis D004751 8 associated lipids
Carcinoma, Embryonal D018236 8 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Genomic Instability D042822 7 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Cytomegalovirus Infections D003586 7 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Leukemia, Myelomonocytic, Acute D015479 6 associated lipids
Polycystic Kidney, Autosomal Dominant D016891 6 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Opioid-Related Disorders D009293 5 associated lipids
Osteomalacia D010018 5 associated lipids
Fragile X Syndrome D005600 5 associated lipids
Cicatrix, Hypertrophic D017439 4 associated lipids
Spinocerebellar Ataxias D020754 4 associated lipids
Nasopharyngeal Neoplasms D009303 4 associated lipids
Neuroendocrine Tumors D018358 4 associated lipids
Porcine Reproductive and Respiratory Syndrome D019318 4 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Lefevre P et al. Identification of factors mediating the developmental regulation of the early acting -3.9 kb chicken lysozyme enhancer element. 2001 Nucleic Acids Res. pmid:11713304
Hsu DW et al. Dynamic acetylation of lysine-4-trimethylated histone H3 and H3 variant biology in a simple multicellular eukaryote. 2012 Nucleic Acids Res. pmid:22600736
Ziesché E et al. The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB. 2013 Nucleic Acids Res. pmid:23087373
Drewell RA et al. Methylation-dependent silencing at the H19 imprinting control region by MeCP2. 2002 Nucleic Acids Res. pmid:11861904
Seuter S et al. Chromatin acetylation at transcription start sites and vitamin D receptor binding regions relates to effects of 1α,25-dihydroxyvitamin D3 and histone deacetylase inhibitors on gene expression. 2013 Nucleic Acids Res. pmid:23093607
Yáñez RJ and Porter AC A chromosomal position effect on gene targeting in human cells. 2002 Nucleic Acids Res. pmid:12433992
Benjamin D and Jost JP Reversal of methylation-mediated repression with short-chain fatty acids: evidence for an additional mechanism to histone deacetylation. 2001 Nucleic Acids Res. pmid:11522830
Hirschler-Laszkiewicz I et al. The role of acetylation in rDNA transcription. 2001 Nucleic Acids Res. pmid:11600700
Kemp MG et al. The histone deacetylase inhibitor trichostatin A alters the pattern of DNA replication origin activity in human cells. 2005 Nucleic Acids Res. pmid:15653633
Allgayer J et al. Widespread transcriptional gene inactivation initiated by a repair intermediate of 8-oxoguanine. 2016 Nucleic Acids Res. pmid:27220469
Khobta A et al. Gene silencing induced by oxidative DNA base damage: association with local decrease of histone H4 acetylation in the promoter region. 2010 Nucleic Acids Res. pmid:20338881
Ferguson M et al. Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene. 2003 Nucleic Acids Res. pmid:12799440
Mao DY et al. Promoter-binding and repression of PDGFRB by c-Myc are separable activities. 2004 Nucleic Acids Res. pmid:15226411
Gialitakis M et al. Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A. 2006 Nucleic Acids Res. pmid:16452299
Hishikawa K and Fujita T [Basic research for renal regeneration]. 2006 Nippon Rinsho pmid:16895225
Hishikawa K and Fujita T [Kidney regeneration update]. 2008 Nippon Rinsho pmid:18464514
Akimoto T [Potentiation of radiation-induced cell killing by histone deacetylase inhibitor]. 2004 Nippon Rinsho pmid:15283155
Ishii T et al. [Epigenetic regulation in alcohol-related brain damage]. 2008 Nihon Arukoru Yakubutsu Igakkai Zasshi pmid:19068777
Dreser N et al. Grouping of histone deacetylase inhibitors and other toxicants disturbing neural crest migration by transcriptional profiling. 2015 Neurotoxicology pmid:26238599
Wang P et al. Trichostatin A protects against cisplatin-induced ototoxicity by regulating expression of genes related to apoptosis and synaptic function. 2013 Neurotoxicology pmid:23558232
Xia J et al. Epigenetic modification of vomeronasal (V2r) precursor neurons by histone deacetylation. 2010 Neuroscience pmid:20594945
Rössler R et al. Differentiation of non-mesencephalic neural stem cells towards dopaminergic neurons. 2010 Neuroscience pmid:20643196
Taura A et al. Histone deacetylase inhibition enhances adenoviral vector transduction in inner ear tissue. 2010 Neuroscience pmid:20060033
Balasubramaniyan V et al. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells. 2006 Neuroscience pmid:17084985
Tao W et al. Histone deacetylase inhibitor-induced emergence of synaptic δ-opioid receptors and behavioral antinociception in persistent neuropathic pain. 2016 Neuroscience pmid:27646288
Wang YJ et al. Histone acetylation in the olfactory bulb of young rats facilitates aversive olfactory learning and synaptic plasticity. 2013 Neuroscience pmid:23262233
Tomioka T et al. The histone deacetylase inhibitor trichostatin A induces neurite outgrowth in PC12 cells via the epigenetically regulated expression of the nur77 gene. 2014 Neurosci. Res. pmid:25128386
Passeri E et al. Enhanced conversion of induced neuronal cells (iN cells) from human fibroblasts: Utility in uncovering cellular deficits in mental illness-associated chromosomal abnormalities. 2015 Neurosci. Res. pmid:26260244
Asaoka N et al. Inhibition of histone deacetylases enhances the function of serotoninergic neurons in organotypic raphe slice cultures. 2015 Neurosci. Lett. pmid:25796177
Baek SY et al. Trichostatin A increases the thermosensitivity of human glioblastoma A172 cells. 2006 Neurosci. Lett. pmid:16384639
Sng JC et al. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation. 2005 Neurosci. Lett. pmid:16002216
Wang Y et al. HDAC inhibitor trichostatin A-inhibited survival of dopaminergic neuronal cells. 2009 Neurosci. Lett. pmid:19835929
Huang L et al. Activation of ATP-sensitive K channels protects hippocampal CA1 neurons from hypoxia by suppressing p53 expression. 2006 Neurosci. Lett. pmid:16426753
Hou Y et al. Expression Profiles of SIRT1 and APP Genes in Human Neuroblastoma SK-N-SH Cells Treated with Two Epigenetic Agents. 2016 Neurosci Bull pmid:27522594
Brown RE et al. Superinduction of leptin mRNA in mouse hypothalamic neurons. 2012 Neuroreport pmid:22964970
Wu JY et al. Enhancement of glutamate uptake in 1-methyl-4-phenylpyridinium-treated astrocytes by trichostatin A. 2008 Neuroreport pmid:18628666
Uchida H and Ito S Differential regulation of expression of RNA-editing enzymes, ADAR1 and ADAR2, by 5-aza-2'-deoxycytidine and trichostatin A in human neuronal SH-SY5Y cells. 2015 Neuroreport pmid:26485095
Rumbaugh G et al. Pharmacological Selectivity Within Class I Histone Deacetylases Predicts Effects on Synaptic Function and Memory Rescue. 2015 Neuropsychopharmacology pmid:25837283
Arora DS et al. Hyposensitivity to gamma-aminobutyric acid in the ventral tegmental area during alcohol withdrawal: reversal by histone deacetylase inhibitors. 2013 Neuropsychopharmacology pmid:23474591
Perisic T et al. Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes. 2010 Neuropsychopharmacology pmid:19924110
Wang L et al. Chronic cocaine-induced H3 acetylation and transcriptional activation of CaMKIIalpha in the nucleus accumbens is critical for motivation for drug reinforcement. 2010 Neuropsychopharmacology pmid:20010550
Green AL et al. Valproate increases dopamine transporter expression through histone acetylation and enhanced promoter binding of Nurr1. 2017 Neuropharmacology pmid:28743636
Suo H et al. NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease. 2015 Neuropharmacology pmid:26188143
Putignano E et al. Developmental downregulation of histone posttranslational modifications regulates visual cortical plasticity. 2007 Neuron pmid:17329213
Renthal W et al. Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. 2007 Neuron pmid:17988634
Korzus E et al. CBP histone acetyltransferase activity is a critical component of memory consolidation. 2004 Neuron pmid:15207240
Vrbova G Spinal muscular atrophy: motoneurone or muscle disease? 2008 Neuromuscul. Disord. pmid:18365338
Fang J et al. Epigenetic modulation of neuronal apoptosis and cognitive functions in sepsis-associated encephalopathy. 2014 Neurol. Sci. pmid:23925573
Börner C et al. Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2'-deoxycytidine. 2012 Neuroimmunomodulation pmid:22262103
Suuronen T et al. Regulation of ER alpha signaling pathway in neuronal HN10 cells: role of protein acetylation and Hsp90. 2008 Neurochem. Res. pmid:18307035
Suuronen T et al. Characterization of the pro-inflammatory signaling induced by protein acetylation in microglia. 2006 Neurochem. Int. pmid:16797784
Aizawa S and Yamamuro Y Involvement of histone acetylation in the regulation of choline acetyltransferase gene in NG108-15 neuronal cells. 2010 Neurochem. Int. pmid:20100532
Saiyed ZM et al. HIV-1 Tat upregulates expression of histone deacetylase-2 (HDAC2) in human neurons: implication for HIV-associated neurocognitive disorder (HAND). 2011 Neurochem. Int. pmid:21315782
Schnichels S et al. Trichostatin A induces cell death at the concentration recommended to differentiate the RGC-5 cell line. 2012 Neurochem. Int. pmid:22391323
Allritz C et al. Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels. 2009 Jul-Aug Neurochem. Int. pmid:19428803
Pandey SC et al. Potential role of adolescent alcohol exposure-induced amygdaloid histone modifications in anxiety and alcohol intake during adulthood. 2015 Neurobiol. Dis. pmid:25814047
Gensert JM et al. CD81, a cell cycle regulator, is a novel target for histone deacetylase inhibition in glioma cells. 2007 Neurobiol. Dis. pmid:17481908
Jayaraman A et al. The epigenetic drug Trichostatin A ameliorates experimental autoimmune encephalomyelitis via T cell tolerance induction and impaired influx of T cells into the spinal cord. 2017 Neurobiol. Dis. pmid:28736194
Vargas-López V et al. Histone deacetylase inhibition abolishes stress-induced spatial memory impairment. 2016 Neurobiol Learn Mem pmid:27544851
Blank M et al. Basolateral amygdala activity is required for enhancement of memory consolidation produced by histone deacetylase inhibition in the hippocampus. 2014 Neurobiol Learn Mem pmid:24583371
Kamitani H et al. Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced. 2002 Neuro-oncology pmid:11916500
Vibhakar R et al. Dickkopf-1 is an epigenetically silenced candidate tumor suppressor gene in medulloblastoma. 2007 Neuro-oncology pmid:17329407
Yu C et al. Mitochondrial Bax translocation partially mediates synergistic cytotoxicity between histone deacetylase inhibitors and proteasome inhibitors in glioma cells. 2008 Neuro-oncology pmid:18445700
Poljakova J et al. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. 2011 Neuro Endocrinol. Lett. pmid:22167207
Trtkova K et al. Binding of AR to SMRT/N-CoR complex and its co-operation with PSA promoter in prostate cancer cells treated with natural histone deacetylase inhibitor NaB. 2010 Neoplasma pmid:20568894
Legartova S et al. Expression of RAN, ZHX-2, and CHC1L genes in multiple myeloma patients and in myeloma cell lines treated with HDAC and Dnmts inhibitors. 2010 Neoplasma pmid:20568903
Halder SK et al. Elucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell lines. 2011 Neoplasia pmid:22028617
Subramanian C et al. CREB-binding protein is a mediator of neuroblastoma cell death induced by the histone deacetylase inhibitor trichostatin A. 2007 Neoplasia pmid:17603632
Fandy TE et al. Interactive effects of HDAC inhibitors and TRAIL on apoptosis are associated with changes in mitochondrial functions and expressions of cell cycle regulatory genes in multiple myeloma. 2005 Neoplasia pmid:16026644
Piazza R et al. Epigenetic silencing of the proapoptotic gene BIM in anaplastic large cell lymphoma through an MeCP2/SIN3a deacetylating complex. 2013 Neoplasia pmid:23633923
Rehni AK et al. Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome. 2012 Naunyn Schmiedebergs Arch. Pharmacol. pmid:22362134
Holownia A et al. Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1. 2014 Naunyn Schmiedebergs Arch. Pharmacol. pmid:24287576
Palazzo A et al. Cell biology: Tubulin acetylation and cell motility. 2003 Nature pmid:12529632
Nicodeme E et al. Suppression of inflammation by a synthetic histone mimic. 2010 Nature pmid:21068722
Jorstad NL et al. Stimulation of functional neuronal regeneration from Müller glia in adult mice. 2017 Nature pmid:28746305
Jih G et al. Unique roles for histone H3K9me states in RNAi and heritable silencing of transcription. 2017 Nature pmid:28682306
Lin RJ et al. Role of the histone deacetylase complex in acute promyelocytic leukaemia. 1998 Nature pmid:9486654
Grignani F et al. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. 1998 Nature pmid:9486655
Magnaghi-Jaulin L et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. 1998 Nature pmid:9468140
Williams RS et al. A common mechanism of action for three mood-stabilizing drugs. 2002 Nature pmid:12015604
Imai S et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. 2000 Nature pmid:10693811
Nan X et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. 1998 Nature pmid:9620804
Eden S et al. DNA methylation models histone acetylation. 1998 Nature pmid:9732866
Zhang J et al. Establishment of transcriptional competence in early and late S phase. 2002 Nature pmid:12432398
Finnin MS et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. 1999 Nature pmid:10490031
Aggarwal BD and Calvi BR Chromatin regulates origin activity in Drosophila follicle cells. 2004 Nature pmid:15254542
Flight MH Behaviour: epigenetically bonded. 2013 Nat. Rev. Neurosci. pmid:23756635
Wang H et al. Histone deacetylase inhibitors facilitate partner preference formation in female prairie voles. 2013 Nat. Neurosci. pmid:23727821
Gundersen B Pair-bonding through epigenetics. 2013 Nat. Neurosci. pmid:23799469
Huang Y et al. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. 1999 Nat. Neurosci. pmid:10491605
Minetti GC et al. Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. 2006 Nat. Med. pmid:16980968
Liu TX et al. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation. 2007 Nat. Med. pmid:17159988
Kim MS et al. Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. 2001 Nat. Med. pmid:11283670
Li J et al. Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasia. 2012 Nat. Med. pmid:22466704
Tao R et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. 2007 Nat. Med. pmid:17922010
Cameron EE et al. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. 1999 Nat. Genet. pmid:9916800
Coffee B et al. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells. 1999 Nat. Genet. pmid:10319871
Bereshchenko OR et al. Acetylation inactivates the transcriptional repressor BCL6. 2002 Nat. Genet. pmid:12402037
Ree AH et al. HDAC2 deficiency and histone acetylation. 2008 Nat. Genet. pmid:18583969
Ng HH et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. 1999 Nat. Genet. pmid:10471499